Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada
- 26 October 2021
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 20 (5) , e1170-e1179
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 28 references indexed in Scilit:
- Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014Liver International, 2019
- Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation studyPLOS ONE, 2018
- Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational studyBMJ, 2018
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseHepatology, 2017
- Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis ConsortiaGastroenterology, 2016
- Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative dataBMC Gastroenterology, 2015
- Use of Administrative Claims Data for Identifying Patients with CirrhosisJournal of Clinical Gastroenterology, 2013
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- Corticosteroid therapy of alcoholic hepatitisGastroenterology, 1978